SCHEMBL7759715

SCHEMBL7759715

NCC(=O)OCCN1CCN(c2cccc3c2C(=O)c2ccccc2C3=O)CC1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.65
NPSR1 Q6W5P4 2/20 0.65
L3MBTL1 Q9Y468 3/20 0.56
TDP1 Q9NUW8 2/20 0.56
EGFR P00533 2/20 0.55
MAPK1 P28482 2/20 0.55
KMT2A Q03164 2/20 0.55
LMNA P02545 1/20 0.55
ALDH1A1 P00352 1/20 0.52
RAF1 P04049 1/20 0.52
ALOX12 P18054 1/20 0.52
MAP2K1 Q02750 1/20 0.52
MEN1 O00255 1/20 0.49
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
DRD2 P14416 6/20 0.46
DRD3 P35462 6/20 0.46
HTR6 P50406 6/20 0.45
KCNH2 Q12809 1/20 0.45
DRD4 P21917 5/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6661975 0.93 MAPT (0.57) MAPTNPSR1L3MBTL1TDP1EGFR
SCHEMBL6660033 0.82 MAPT (0.56) MAPTNPSR1L3MBTL1TDP1EGFR
SCHEMBL6661677 0.80 MAPT (1.00) MAPTNPSR1L3MBTL1TDP1EGFR
SCHEMBL2463193 0.70 MAPT (1.00) MAPTNPSR1L3MBTL1TDP1EGFR
SCHEMBL3273424 0.69 MAPT (0.97) MAPTNPSR1L3MBTL1TDP1EGFR
SCHEMBL10365727 0.68 ADORA2B (0.55) LMNAALDH1A1DRD2DRD3DRD4
SCHEMBL7290042 0.68 DRD3 (0.48) MAPTNPSR1KMT2ALMNAALDH1A1
SCHEMBL7063615 0.68 DPP7 (0.52) MAPTNPSR1L3MBTL1TDP1EGFR
SCHEMBL3418386 0.68 MAPT (0.90) MAPTNPSR1L3MBTL1TDP1EGFR
SCHEMBL6660403 0.68 MAPT (0.69) MAPTNPSR1L3MBTL1TDP1EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1087935-A1 ANTHRACENE DERIVATIVES AS ANTI-CANCER AGENTS BTG INTERNATIONAL LIMITED (GB) 2001-04-04 EP disclosed
WO-1999065866-A1 ANTHRACENE DERIVATIVES AS ANTI-CANCER AGENTS BTG INTERNATIONAL LIMITED (GB) 1999-12-23 WO disclosed